Hot Features
プレミアム
MacroGenics Inc (MGNX)
NASDAQ
ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | Dr. Jay Philip Siegelインサイダー | 3.75k | 0.00 | Derivative Exercise and Retained Stock | - | 14.75k | 34.09% |
| 2026-05-18 | Mr. Scott T. JacksonIndependent Director | 3.75k | 0.00 | Derivative Exercise and Retained Stock | - | 14.75k | 34.09% |
| 2026-05-18 | Dr. Margaret A. LiuIndependent Director | 3.75k | 0.00 | Derivative Exercise and Retained Stock | - | 14.75k | 34.09% |
| 2026-05-18 | Ms. Meenu Chhabra KarsonIndependent Director | 3.75k | 0.00 | Derivative Exercise and Retained Stock | - | 14.75k | 34.09% |
| 2026-05-18 | Dr. William K. HeidenIndependent Chairman of the Board | 3.75k | 0.00 | Derivative Exercise and Retained Stock | - | 114.75k | 3.38% |
| 2026-05-18 | Ms. Federica F. O'BrienIndependent Director | 3.75k | 0.00 | Derivative Exercise and Retained Stock | - | 14.75k | 34.09% |
| 2026-05-18 | Mr. Edward M. HurwitzIndependent Director | 3.75k | 0.00 | Derivative Exercise and Retained Stock | - | 47.82k | 8.51% |
| 2026-05-18 | Dr. David C. StumpIndependent Director | 3.75k | 0.00 | Derivative Exercise and Retained Stock | - | 14.75k | 34.09% |
| 2026-05-18 | Dr. Karen Jean FerranteIndependent Director | 3.75k | 0.00 | Derivative Exercise and Retained Stock | - | 14.75k | 34.09% |
| 2026-02-15 | Dr. Ezio BonviniSenior VP of Research & Chief Scientific Officer | 10.23k | 0.00 | Derivative Exercise and Retained Stock | - | 145.80k | 7.55% |
| 2026-02-15 | Dr. Ezio BonviniSenior VP of Research & Chief Scientific Officer | -6.43k | 11.00k | Derivative Exercise and Sale | 1.71 | 145.80k | - |
| 2026-02-15 | Mr. James KarrelsSenior VP & CFO | 9.21k | 0.00 | Derivative Exercise and Retained Stock | - | 206.04k | 4.68% |
| 2026-02-15 | Mr. James KarrelsSenior VP & CFO | -5.79k | 9.90k | Derivative Exercise and Sale | 1.71 | 206.04k | - |
| 2026-02-15 | Ms. Beth SmithVP, Controller & Treasurer | 672.00 | 0.00 | Derivative Exercise and Retained Stock | - | 12.78k | 5.55% |
| 2026-02-15 | Ms. Beth SmithVP, Controller & Treasurer | -423.00 | 723.33 | Derivative Exercise and Sale | 1.71 | 12.78k | - |
| 2026-02-15 | Mr. Jeffrey Stuart PetersSenior VP, Corporate Secretary, General Counsel & Corporate Compliance Officer | 8.19k | 0.00 | Derivative Exercise and Retained Stock | - | 31.11k | 35.71% |
| 2026-02-15 | Mr. Jeffrey Stuart PetersSenior VP, Corporate Secretary, General Counsel & Corporate Compliance Officer | -5.15k | 8.80k | Derivative Exercise and Sale | 1.71 | 31.11k | - |
| 2026-02-15 | Dr. Thomas M. SpitznagelSVP of Technical Operations | 7.81k | 0.00 | Derivative Exercise and Retained Stock | - | 38.54k | 25.42% |
| 2026-02-15 | Mr. Eric Blasius RisserCEO, President & Director | 10.23k | 0.00 | Derivative Exercise and Retained Stock | - | 77.17k | 15.29% |
| 2026-02-15 | Mr. Eric Blasius RisserCEO, President & Director | -6.43k | 11.00k | Derivative Exercise and Sale | 1.71 | 77.17k | - |
| 2026-02-15 | Dr. Thomas M. SpitznagelSVP of Technical Operations | -5.52k | 9.44k | Derivative Exercise and Sale | 1.71 | 38.54k | - |
| 2026-02-15 | Dr. Scott KoenigDirector | 21.17k | 0.00 | Derivative Exercise and Retained Stock | - | 867.24k | 2.50% |
| 2026-02-08 | Dr. Scott KoenigDirector | 15.83k | 0.00 | Derivative Exercise and Retained Stock | - | 846.08k | 1.91% |
| 2026-02-07 | Dr. Thomas M. SpitznagelSVP of Technical Operations | 9.33k | 0.00 | Derivative Exercise and Retained Stock | - | 30.73k | 43.59% |
| 2026-02-07 | Dr. Thomas M. SpitznagelSVP of Technical Operations | -5.67k | 10.26k | Derivative Exercise and Sale | 1.81 | 30.73k | - |
| 2026-02-07 | Mr. Eric Blasius RisserCEO, President & Director | 10.95k | 0.00 | Derivative Exercise and Retained Stock | - | 66.94k | 19.55% |
| 2026-02-07 | Mr. Eric Blasius RisserCEO, President & Director | -6.89k | 12.46k | Derivative Exercise and Sale | 1.81 | 66.94k | - |
| 2026-02-07 | Ms. Beth SmithVP, Controller & Treasurer | 2.58k | 0.00 | Derivative Exercise and Retained Stock | - | 12.11k | 27.04% |
| 2026-02-07 | Ms. Beth SmithVP, Controller & Treasurer | -1.62k | 2.94k | Derivative Exercise and Sale | 1.81 | 12.11k | - |
| 2026-02-07 | Mr. Jeffrey Stuart PetersSenior VP, Corporate Secretary, General Counsel & Corporate Compliance Officer | 9.21k | 0.00 | Derivative Exercise and Retained Stock | - | 22.92k | 67.17% |
| 2026-02-07 | Mr. Jeffrey Stuart PetersSenior VP, Corporate Secretary, General Counsel & Corporate Compliance Officer | -5.79k | 10.48k | Derivative Exercise and Sale | 1.81 | 22.92k | - |
| 2026-02-07 | Dr. Ezio BonviniSenior VP of Research & Chief Scientific Officer | 11.15k | 0.00 | Derivative Exercise and Retained Stock | - | 135.57k | 8.96% |
| 2026-02-07 | Dr. Ezio BonviniSenior VP of Research & Chief Scientific Officer | -7.01k | 12.70k | Derivative Exercise and Sale | 1.81 | 135.57k | - |
| 2026-02-07 | Mr. James KarrelsSenior VP & CFO | 10.03k | 0.00 | Derivative Exercise and Retained Stock | - | 196.83k | 5.37% |
| 2026-02-07 | Mr. James KarrelsSenior VP & CFO | -6.31k | 11.41k | Derivative Exercise and Sale | 1.81 | 196.83k | - |
| 2025-08-19 | Dr. William K. HeidenIndependent Chairman of the Board | 100.00k | 150.52k | 買い | 1.49 - 1.52 | 111.00k | 909.09% |
| 2025-08-13 | Dr. Scott KoenigDirector | 52.83k | 0.00 | Derivative Exercise and Retained Stock | - | 830.24k | 6.80% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
